You'll also hear from some great panelists --Adam Markovitz, MD, PhD on Medicare Advantage, --Amol Navathe on Joint Replacement Bundled Payments, -- Caroline Thirukumaran on the Comprehensive Care for Joint Replacement Model #ARM21 OR (2/3)

Medicare Advantage plans receive $11.6 billion in quality bonus payments annually Andrew Ryan & Adam Markovitz, MD, PhD share research on what we've 'bought' with these bonuses Unfortunately, the answer appears to be not much... #ASHEcon2021

We have a paper out in the new issue of Health Affairs about financial incentives for quality in Medicare Advantage led by Adam Markovitz, MD, PhD with John Z. Ayanian and @awarrier1221 healthaffairs.org/doi/10.1377/hl… Title kind of says it all, but here’s a thread anyway 1/6

Andrew Ryan Health Affairs Adam Markovitz, MD, PhD John Z. Ayanian @awarrier1221 MedPAC So what you’re saying is we need triple bonuses

Absolutely stoked to summarize a paper out in the new issue of Health Affairs led by Adam Markovitz, MD, PhD with John Z. Ayanian and Devraj Sukul, MD MS healthaffairs.org/doi/full/10.13… Don’t let the title fool you… just kidding, the title pretty much covers it. Here’s a thread anyway. 1/7

No impact of CPC+ on spending or quality for patients with private insurance in MI Figuring out ways to deliver good care in settings under the influence of the “Quality-Industrial Complex”— Adam Markovitz, MD, PhD at #SGIM22

What a gratifying and humbling experience to work with this amazing team for the last 2 weeks 🙏🌟 #IMProud Adam Markovitz, MD, PhD Grecia Quiroga @UMichIMRes UMich Med Peds U-M Department of Internal Medicine

At the #ASHEcon2022 “Evaluation of Payment Reform Programs” session, I’m presenting my research with Andrew Ryan & Adam Markovitz, MD, PhD evaluating the Comprehensive Primary Care Plus demonstration for private payers in Michigan. Please come by Tues @ 1:45 ashecon.confex.com/ashecon/2022/m…

He is the best of humans…and also the best of health policy scientists…Andrew Ryan will be missed U-M IHPI. Ashish K. Jha is getting a great one at Brown University School of Public Health!

Does CPC+ improve spending & quality in the private sector? In Health Affairs, Adam Markovitz, MD, PhD, Andrew Ryan, and I evaluate the effect of CPC+ implemented by private payers in Michigan. We find it did not reduce spending or improve quality outcomes healthaffairs.org/doi/epdf/10.13…

We are recruiting MD & PhD research faculty at all levels!! Please check out our job posting & DM me if you would like to hear about the great people & resources like U-M IHPI, VA CCMR, & more that make the U-M Department of Internal Medicine Division of General Medicine such a special place to work!

New paper out in JAMA Health Forum with Ishani Ganguli MD, MPH, @EGolberstein John Mulcahy, Dori Cross, and Joe Gaugler! Seems only appropriate that this 🧵 (for a paper about the importance of ⏱️ in primary care) is a bit delayed… jamanetwork.com/journals/jama-…

Congratulations to all the incoming Michigan Medicine residents who just found out their destination as part of #Match2023! (Including University of Michigan Medical School students matching here!) If you're interested in #HealthServicesResearch, you are coming to the right place! #GoBlueMatch

TLDR: I wrote a paper with Karen Joynt Maddox Jason D Buxbaum Sukruth Shashikumar zoey chopra We found that BPCI-A, CMS’ bundled payment program, appeared to lose money: bit.ly/3zO6EAH Then Zhenke Wu (吴振科), Qiyuan Shi, and I created a tool to redesign BPCI-A: bit.ly/3ZV2qSy 1/6

Physician payment reform is in the air. So I wanted to share our paper about the Medicare Shared Savings Program. We find that the MSSP has had virtually no budget impact for CMS. ACOs are not the answer to cost containment in Traditional Medicare. tinyurl.com/32emjerw

And even if we assume the MSSP lowered medical spend by ~2% in Traditional Medicare, the MSSP lost CMS $ bc ACO bonus payments raise total FFS spending, which drives up MA benchmarks and thus MA plan payments, raising net CMS spend across the two programs jamanetwork.com/journals/jama-…

🚨I've posted BRFSS data in SAS, R, and Stata formats for 1987-2023 here on this Mendeley Data Repository Free to use without restriction! data.mendeley.com/datasets/shs97…

In Health Affairs, we counter the govt’s claim that its flagship value-based payment model, the ACO program, is reducing costs. Rather, purported savings reflect benchmarking flaws & industry gaming—the same factors inflating costs in ACO sister model, Medicare Advantage. 1/x

My interpretation of this evidence is different. IMO, the authors present compelling evidence that ACOs selected healthier benes and coded them to look sicker. Unfortunately the analysis does not account for selection bias and upcoding. It’s unlikely that ACOs saved money

In their new Forefront article, James Lee, Cody Lendon Mullens, Adam Markovitz, MD, PhD, and Janice Probst from University of Michigan discuss how the expansion of Medicare Advantage (MA) in rural areas highlights a policy paradox: Despite long-standing efforts by the federal government to protect rural